EADV人工智能工作组关于皮肤病AI手机应用与网络服务的立场声明
欧洲皮肤病与性病学会(EADV)人工智能工作组基于文献综述起草立场声明,经两轮数字讨论与反馈修订,识别出八项关键考量并提出三条主要建议:开发者应优先确保数据质量、准确性、预期用途、隐私和成本的透明度;应用与网络服务应确保不同患者群体获得统一用户体验;欧洲监管机构应采用严格且一致的监管框架。
要点
- AI辅助皮肤病应用可提供即时诊断指导与教育资源,包括皮肤癌检测。
- 需关注不准确与用户教育不当、专业技能下降、非医疗商业利益等风险。
- 建议开发者优先确保数据质量、准确性、预期用途、隐私和成本的透明度。
核心结论
- AI辅助智能手机应用和网络服务在皮肤病诊疗中有望极大惠及患者,但需优先创新、促进合作并实施有效监管以确保成功整合。
研究设计与样本
- EADV AI工作组基于全面文献综述起草初始立场声明,经两轮数字讨论和细致反馈修订。
主要发现
- 识别出八项关键考量:不准确与用户教育不当的风险、专业技能下降、非医疗商业利益的影响、数据安全、直接和间接成本、监管批准以及多学科实施的必要性。
关键数值与推荐
- 建议1:为确保用户信任,应用开发者应优先保证数据质量、准确性、预期用途、隐私和成本的透明度。
- 建议2:应用和网络服务应确保不同患者群体获得统一的用户体验。
- 建议3:欧洲监管机构应采用严格且一致的皮肤病学应用监管框架,以确保用户的安全性和准确性。
临床怎么用
- 开发者应优先保证数据质量、准确性、预期用途、隐私和成本的透明度以建立用户信任。
- 应用和网络服务应确保不同患者群体获得统一的用户体验。
- 欧洲监管机构应采用严格且一致的监管框架以确保皮肤病学应用的安全性和准确性。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As the use of smartphones continues to surge globally, mobile applications (apps) have become a powerful tool for healthcare engagement. Prominent among these are dermatology apps powered by Artificial Intelligence (AI), which provide immediate diagnostic guidance and educational resources for skin diseases, including skin cancer. OBJECTIVE: This article, authored by the EADV AI Task Force, seeks to offer insights and recommendations for the present and future deployment of AI-assisted smartphone applications (apps) and web-based services for skin diseases with emphasis on skin cancer detection. METHODS: An initial position statement was drafted on a comprehensive literature review, which was subsequently refined through two rounds of digital discussions and meticulous feedback by the EADV AI Task Force, ensuring its accuracy, clarity and relevance. RESULTS: Eight key considerations were identified, including risks associated with inaccuracy and improper user education, a decline in professional skills, the influence of non-medical commercial interests, data security, direct and indirect costs, regulatory approval and the necessity of multidisciplinary implementation. Following these considerations, three main recommendations were formulated: (1) to ensure user trust, app developers should prioritize transparency in data quality, accuracy, intended use, privacy and costs; (2) Apps and web-based services should ensure a uniform user experience for diverse groups of patients; (3) European authorities should adopt a rigorous and consistent regulatory framework for dermatology apps to ensure their safety and accuracy for users. CONCLUSIONS: The utilisation of AI-assisted smartphone apps and web-based services in diagnosing and treating skin diseases has the potential to greatly benefit patients in their dermatology journeys. By prioritising innovation, fostering collaboration and implementing effective regulations, we can ensure the successful integration of these apps into clinical practice.
引用
- Sangers TE, Kittler H, Blum A, et al. Position statement of the EADV Artificial Intelligence (AI) Task Force on AI-assisted smartphone apps and web-based services for skin disease. J Eur Acad Dermatol Venereol. 2023. PMID: 37766502. doi:10.1111/jdv.19521
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。